ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Aisha T. Langford, PhD, MPH

Aisha T. Langford, PhD, MPH

Aisha T. Langford, PhD, MPH, is a freelance writer, speaker and academic researcher. She holds an appointment with the NYU School of Medicine as an assistant professor. Her research focuses on how health communication can improve individual medical decision making and reduce population health disparities in the context of clinical trial participation and chronic disease prevention. Dr. Langford holds a BA in English from the University of Virginia, an MPH in behavioral science and epidemiology from Saint Louis University School of Public Health, and a Ph.D. in health behavior and health education from the University of Michigan School of Public Health. 

Posts by Author

(©Masycheva/Shutterstock.com)

Systemic sclerosis. Its rarity could lead to delays in diagnosis which, according to a review, may not be fully understood by inexperienced physicians.

(©Toa55/Shutterstock.com)

Study of long-term outcomes in rheumatoid arthritis supports early window of opportunity treatment theory.

Knee OA (©PuwadolJaturawutthichai/Shutterstock.com)

Despite monthly dosing regimen and long half-life of fulranumab, patients experienced pain relief within a short period of time.

Pediatric care (©StockLite/Shutterstock.com)

The combination therapy only slightly outperformed standard corticosteroid treatment in a trial for juvenile idiopathic arthritis.

Naproxen Pollapat (©Chirawong/Shutterstock.com)

Celecoxib is preferred over naproxen for arthritis patients at high risk for cardiovascular and gastrointestinal events, researchers report.

©KPG_Payless/Shutterstock.com

A history of having taken biologics affects whether patients will adhere to prescribed TNFi therapy, researchers show.

Lung disease in women (©BenSchonewille/Shutterstock.com)

Glucocorticoids exposure is strongly associated with irreversible organ damage in systemic lupus erythematosus, researchers report.

DAS28 (©ChaowalitSeeneha/Shutterstock.com).JPG

Achieving remission in rheumatoid arthritis may depend on which disease activity measure you use.

Chronic pain (©Lightspring/Shutterstock.com)

DMARDs and surgery are unlikely to be effective as sole therapies when central pain vs. peripheral pain is suspected in lupus, RA and osteoarthritis.

(Prescriptions. ©megaflopp/Shutterstock.com)

Prescribing opioids for chronic pain may be associated with some short-term efficacy, but there may be other alternatives physicians should consider.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.